| Literature DB >> 31315557 |
Éva Csősz1, Ferenc Tóth2, Mohamed Mahdi2, George Tsaprailis3,4, Miklós Emri5, József Tőzsér6,7.
Abstract
BACKGROUND: Utilization of quantitative proteomics data on the network level is still a challenge in proteomics data analysis. Currently existing models use sophisticated, sometimes hard to implement analysis techniques. Our aim was to generate a relatively simple strategy for quantitative proteomics data analysis in order to utilize as much of the data generated in a proteomics experiment as possible.Entities:
Keywords: HIV-1; Host response; Quantitative proteomics; Weighted network
Mesh:
Substances:
Year: 2019 PMID: 31315557 PMCID: PMC6637640 DOI: 10.1186/s12859-019-2990-3
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Fig. 1Relative protein amounts showing statistically significant changes in HIV-1 treated samples compared to controls. The x axis shows the time-points of sample collection in hours, and the y axis shows the relative protein amounts. Blue color refers to control (C), and yellow color to the HIV-1 treated sample (H)
Fig. 2Protein-protein interaction network of the proteins quantified in each condition. The PPI networks were generated by STRING (confidence 0.95) using the list of quantified proteins presented in Additional file 2 in case of each condition. The number of nodes (N) and the number of edges (E) according to STRING in case of each network is indicated. a. PPI network of proteins in the 0 h time point (NW), b. PPI network of proteins in the 4 h time point in control, mock-transduced cells (C04). c PPI network of proteins in the 12 h time point in control, mock-transduced cells (C12). d. PPI network of proteins in the 4 h time point in HIV vector-transduced cells (H04). e. PPI network of proteins in the 12 h time point in HIV vector- transduced cells (H12). Red dots represent proteins belonging to transport GO term, blue dots indicate proteins having a role in translation, while green dots indicate proteins with a role in RNA splicing according to the functional enrichment analysis provided by STRING
Fig. 3Network generation pipeline. Representative network drawn by circlize, showing data for sample1 and interactions generated by STRING. a. Binary network containing all the identified proteins arranged in alphabetical order on the external ring of the circular plot. Thin black curves show the possible interactions generated by STRING. b. Binary network containing only the proteins with interactions. The isolated proteins (i.e. without any connection) were eliminated. Thin black curves show the possible interactions generated by STRING. c. Weighted network containing the interacting proteins. Orange lines represent interactions, the higher the intensity of the color and thickness of the line the higher the interaction strength. d. Weighted network with functional feature. A randomly selected GO function (GO:0044765) is used to illustrate the functional network. Red proteins are part of the functional sub-network, while black proteins are not, being considered as non-functional proteins. The weighted interactions are color-coded according to the protein-pair classification: functional – functional interactions are orange, non-functional – non-functional interactions are gray, and functional – non-functional interactions are green. The interaction strength is represented by the intensity of the color and thickness of the line: the higher the intensity of the color and the thickness of the line, the higher the interaction strength
Fig. 4Network parameters. a. Number of nodes (N), b. number of edges (E), c. network strength (S), d. strength or edge density (D) in case of networks observed in the examined conditions. The y axis show the mean value characteristic for each parameter, and the x axis indicates the time points. Blue color refers to control, while the yellow color to the HIV-1 treated conditions
Fig. 5Network changes visualized in case of a representative functional sub-network. The representative figure shows the changes in weighted networks in case of proteins belonging to randomly selected GO:0044765 GO term. NW represents the weighted PPI network of interacting proteins in the 0 h time point, C04 and C12 correspond to PPI networks of interacting proteins in the 4 h and 12 h time point, respectively, in control, mock-transduced cells. H04 and H12 represent the weighted PPI network of interacting proteins in the 4 h and 12 h time point, respectively, in HIV vector-transduced cells. Red proteins are part of the functional sub-network, while black proteins are non-functional proteins. The weighted interactions are color-coded according to the protein-pair classification: functional – functional interactions are orange, non-functional – non-functional interactions are gray, and functional – non-functional interactions are green. The interaction strength is represented by the intensity of the color and thickness of the line: the higher the intensity of the color and the thickness of the line, the higher the interaction strength
List of GO terms with significantly different changes in the functional sub-network in H04
| GO code | GO term | Significantly changed parameter | Direction of change in H04 |
|---|---|---|---|
| GO.0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | Df | decrease |
| GO.0000228 | nuclear chromosome | Df | decrease |
| GO.0000375 | RNA splicing, via transesterification reactions | Df | decrease |
| GO.0000398 | mRNA splicing, via spliceosome | Df | decrease |
| GO.0000956 | nuclear-transcribed mRNA catabolic process | Df | decrease |
| GO.0003735 | structural constituent of ribosome | Df | decrease |
| GO.0005198 | structural molecule activity | Df | decrease |
| GO.0005515 | protein binding | Df | decrease |
| GO.0005524 | ATP binding | Df, Dc | decrease |
| GO.0005622 | intracellular | Df | decrease |
| GO.0005737 | cytoplasm | Df | decrease |
| GO.0005739 | mitochondrion | Df | decrease |
| GO.0005840 | ribosome | Df | decrease |
| GO.0006351 | transcription, DNA-templated | Df, Dc | decrease |
| GO.0006366 | transcription from RNA polymerase II promoter | Df, Dc | decrease |
| GO.0006367 | transcription initiation from RNA polymerase II promoter | Df | decrease |
| GO.0006396 | termination of RNA polymerase II transcription | Df | decrease |
| GO.0006397 | mRNA processing | Df | decrease |
| GO.0006401 | RNA catabolic process | Df | decrease |
| GO.0006402 | mRNA catabolic process | Df | decrease |
| GO.0006412 | translation | Df | decrease |
| GO.0006413 | translational initiation | Df, Dc | decrease |
| GO.0006414 | translational elongation | Df, Dc | decrease |
| GO.0006415 | translational termination | Df | decrease |
| GO.0006417 | regulation of translation | Df, Dc | decrease |
| GO.0006518 | peptide metabolic process | Df | decrease |
| GO.0006605 | protein targeting | Df | decrease |
| GO.0006614 | SRP-dependent cotranslational protein targeting to membrane | Df | decrease |
| GO.0006732 | coenzyme metabolic process | Df, Dc | decrease |
| GO.0006886 | intracellular protein transport | Df | decrease |
| GO.0008104 | protein localization | Rf | decrease |
| GO.0008152 | metabolic process | Df | decrease |
| GO.0008380 | RNA splicing | Df | decrease |
| GO.0009056 | catabolic process | Df | decrease |
| GO.0009892 | negative regulation of metabolic process | Df | decrease |
| GO.0009987 | cellular process | Df | decrease |
| GO.0010468 | regulation of gene expression | Df | decrease |
| GO.0010556 | regulation of macromolecule biosynthetic process | Df | decrease |
| GO.0010608 | posttranscriptional regulation of gene expression | Df, Dc | decrease |
| GO.0010941 | regulation of cell death | Df | decrease |
| GO.0015031 | protein transport | Df | decrease |
| GO.0016032 | viral process | Df | increase |
| GO.0016043 | cellular component organization | Df | decrease |
| GO.0016070 | RNA metabolic process | Df, Dc | decrease |
| GO.0016071 | mRNA metabolic process | Df | decrease |
| GO.0016482 | cytoplasmic transport | Df | decrease |
| GO.0016604 | nuclear body | Df, Dc | decrease |
| GO.0017076 | purine nucleotide binding | Df, Dc | decrease |
| GO.0018130 | heterocycle biosynthetic process | Df, Dc | decrease |
| GO.0019058 | viral life cycle | Df | decrease |
| GO.0019080 | viral gene expression | Df | decrease |
| GO.0019083 | viral transcription | Df | decrease |
| GO.0019222 | regulation of metabolic process | Df | decrease |
| GO.0019438 | aromatic compound biosynthetic process | Df, Dc | decrease |
| GO.0019538 | aromatic compound biosynthetic process | Df | decrease |
| GO.0019899 | enzyme binding | Df | decrease |
| GO.0019900 | kinase binding | Df, Dc | increase |
| GO.0019901 | protein kinase binding | Df | increase |
| GO.0022607 | cellular component assembly | Df | decrease |
| GO.0022626 | cytosolic ribosome | Df | decrease |
| GO.0030554 | adenyl nucleotide binding | Df, Dc | decrease |
| GO.0031625 | ubiquitin protein ligase binding | Df, Dc | decrease |
| GO.0031974 | membrane-enclosed lumen | Df | decrease |
| GO.0032550 | purine ribonucleoside binding | Df, Dc | decrease |
| GO.0032553 | ribonucleotide binding | Df, Dc | decrease |
| GO.0032555 | purine ribonucleotide binding | Df, Dc | decrease |
| GO.0032774 | RNA biosynthetic process | Df, Dc | decrease |
| GO.0034248 | regulation of cellular amide metabolic process | Df | decrease |
| GO.0034613 | cellular protein localization | Rf | decrease |
| GO.0034622 | cellular macromolecular complex assembly | Df | decrease |
| GO.0034645 | cellular macromolecule biosynthetic process | Df | decrease |
| GO.0034654 | nucleobase-containing compound biosynthetic process | Df, Dc | decrease |
| GO.0034655 | nucleobase-containing compound catabolic process | Df | decrease |
| GO.0035639 | purine ribonucleoside triphosphate binding | Df, Dc | decrease |
| GO.0036094 | small molecule binding | Df, Dc | decrease |
| GO.0042981 | regulation of apoptotic process | Df | decrease |
| GO.0043065 | positive regulation of apoptotic process | Df | decrease |
| GO.0043066 | negative regulation of apoptotic process | Df, Dc | decrease |
| GO.0043226 | organelle | Df | decrease |
| GO.0043227 | membrane-bounded organelle | Df, Dc | decrease |
| GO.0043229 | intracellular organelle | Df | decrease |
| GO.0043231 | intracellular membrane-bounded organelle | Df | decrease |
| GO.0043233 | organelle lumen | Df | decrease |
| GO.0044085 | cellular component biogenesis | Df | decrease |
| GO.0044237 | cellular metabolic process | Df | decrease |
| GO.0044238 | primary metabolic process | Df | decrease |
| GO.0044248 | cellular catabolic process | Df | decrease |
| GO.0044249 | cellular biosynthetic process | Df | decrease |
| GO.0044260 | cellular macromolecule metabolic process | Df | decrease |
| GO.0044265 | cellular macromolecule catabolic process | Df | decrease |
| GO.0044267 | cellular protein metabolic process | Df | decrease |
| GO.0044271 | cellular nitrogen compound biosynthetic process | Df, Dc | decrease |
| GO.0044391 | ribosomal subunit | Df | decrease |
| GO.0044422 | organelle part | Df | decrease |
| GO.0044424 | intracellular part | Df | decrease |
| GO.0044444 | cytoplasmic part | Df | decrease |
| GO.0044446 | intracellular organelle part | Df | decrease |
| GO.0044451 | nucleoplasm part | Df, Dc | decrease |
| GO.0044454 | nuclear chromosome part | Df | decrease |
| GO.0044802 | single-organism membrane organization | Df, Dc | decrease |
| GO.0045184 | establishment of protein localization | Df | decrease |
| GO.0046907 | intracellular transport | Df, Dc | decrease |
| GO.0051084 | de novo posttranslational protein folding | Df | increase |
| GO.0051704 | multi-organism process | Df, Dc | increase |
| GO.0060255 | regulation of macromolecule metabolic process | Df | decrease |
| GO.0060548 | negative regulation of cell death | Df, Dc | decrease |
| GO.0065003 | macromolecular complex assembly | Df | decrease |
| GO.0070013 | intracellular organelle lumen | Df | decrease |
| GO.0070972 | protein localization to endoplasmic reticulum | Rf | decrease |
| GO.0071013 | catalytic step 2 spliceosome | Df | decrease |
| GO.0071702 | organic substance transport | Df, Dc | decrease |
| GO.0071704 | organic substance metabolic process | Df | decrease |
| GO.0071705 | nitrogen compound transport | Df, Dc | decrease |
| GO.0071822 | protein complex subunit organization | Df | increase |
| GO.0071840 | cellular component organization or biogenesis | Df | decrease |
| GO.0072594 | establishment of protein localization to organelle | Df | decrease |
| GO.0080090 | regulation of primary metabolic process | Df | decrease |
| GO.0080135 | regulation of cellular response to stress | Df, Dc | decrease |
| GO.0090304 | nucleic acid metabolic process | Df, Dc | decrease |
| GO.0097367 | carbohydrate derivative binding | Df, Dc | decrease |
| GO.1901362 | organic cyclic compound biosynthetic process | Df, Dc | decrease |
| GO.1901566 | organonitrogen compound biosynthetic process | Df | decrease |
| GO.1901575 | organic substance catabolic process | Df | decrease |
| GO.1901576 | organic substance biosynthetic process | Df | decrease |
| GO.1902580 | single-organism cellular localization | Df | decrease |
In case of each GO term where statistically significant changes were observed in network parameters in HIV-1 treated cells at 4 h time-point the GO identifier, the changed parameter and the direction of change is indicated
List of GO terms with significantly different changes in the functional sub-networks in H12
| GO code | GO term | Significantly changed parameter | Direction of change in H12 |
|---|---|---|---|
| GO.0005759 | mitochondrial matrix | Nf | decrease |
| GO.0003674 | molecular function | Df, Dc | increase |
| GO.0003723 | RNA binding | Rf, Rc | increase |
| GO.0005488 | binding | Df, Dc | increase |
| GO.0005615 | extracellular space | Rf, Rc | increase |
| GO.0005634 | nucleus | Df, Dc | increase |
| GO.0005654 | nucleoplasm | Df, Dc | increase |
| GO.0005739 | mitochondrion | Df | increase |
| GO.0005743 | mitochondrial inner membrane | Df, Dc | increase |
| GO.0005759 | mitochondrial matrix | Df | increase |
| GO.0005856 | cytoskeleton | Df, Dc | increase |
| GO.0006401 | RNA catabolic process | Df, Dc | increase |
| GO.0006402 | mRNA catabolic process | Df, Dc | increase |
| GO.0009058 | biosynthetic process | Rf, Rc | decrease |
| GO.0009987 | cellular process | Df, Dc | increase |
| GO.0010467 | gene expression | Rf, Rc | increase |
| GO.0016032 | viral process | Rf | increase |
| GO.0016604 | nuclear body | Nf | decrease |
| GO.0017076 | purine nucleotide binding | Df, Dc | increase |
| GO.0019058 | viral life cycle | Df, Dc | increase |
| GO.0022607 | cellular component assembly | Df | increase |
| GO.0030054 | cell junction | Df | increase |
| GO.0031966 | mitochondrial membrane | Df, Dc | increase |
| GO.0031981 | nuclear lumen | Df, Dc | increase |
| GO.0043066 | negative regulation of apoptotic process | Df | increase |
| GO.0043209 | myelin sheath | Df | increase |
| GO.0043232 | intracellular non-membrane-bounded organelle | Df | increase |
| GO.0043933 | macromolecular complex subunit organization | Rf, Rc | increase |
| GO.0044237 | cellular metabolic process | Df | increase |
| GO.0044265 | mitochondrial nucleoid | Df, Dc | increase |
| GO.0044428 | nuclear part | Df, Dc | increase |
| GO.0044430 | cytoskeletal part | Df, Dc | increase |
| GO.0044451 | nucleoplasm part | Nf | decrease |
| GO.0044712 | single-organism catabolic process | Nf | decrease |
| GO.0044765 | single-organism transport | Df, Dc | increase |
| GO.0044822 | poly(A) RNA binding | Rf | increase |
| GO.0051084 | de novo posttranslational protein folding | Rf, Rc | increase |
| GO.0051704 | multi-organism process | Rf, Rc | increase |
| GO.0060548 | negative regulation of cell death | Df | increase |
| GO.0071013 | catalytic step 2 spliceosome | Df | increase |
| GO.0071705 | nitrogen compound transport | Nf | decrease |
| GO.0071822 | protein complex subunit organization | Rf | increase |
| GO.1901575 | organic substance catabolic process | Df | increase |
In case of each GO term where statistically significant changes were observed in network parameters in HIV-1 treated cells at 12 h time-point the GO identifier, the changed parameter and the direction of change is indicated